CABALETTA BIO, INC. (CABA): Price and Financial Metrics
CABA Price/Volume Stats
Current price | $2.71 | 52-week high | $25.05 |
Prev. close | $2.70 | 52-week low | $1.76 |
Day low | $2.70 | Volume | 1,162,500 |
Day high | $2.88 | Avg. volume | 1,313,123 |
50-day MA | $2.57 | Dividend yield | N/A |
200-day MA | $5.60 | Market Cap | 132.46M |
CABA Stock Price Chart Interactive Chart >
CABALETTA BIO, INC. (CABA) Company Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
CABA Price Returns
1-mo | -1.09% |
3-mo | 6.69% |
6-mo | -54.07% |
1-year | -88.15% |
3-year | 11.52% |
5-year | -83.90% |
YTD | 19.38% |
2024 | -90.00% |
2023 | 145.41% |
2022 | 144.06% |
2021 | -69.63% |
2020 | -10.67% |
Loading social stream, please wait...